HomeSearch › Kevin Tabb, MD

Kevin Tabb, MD

CEO (EX-OFF) (CEO, BILH) at BETH ISRAEL LAHEY HEALTH PHARMACY INC · MA · Healthcare

$5.4M
Peak Total Compensation
5
Years Tracked
72x
vs. Median Household

Kevin Tabb, MD has appeared in compensation disclosures over 5 years of available data (2018–2024). Total compensation changed from $1,798,497 to $5,410,415 - a 200.8% increase.

Peak total compensation of $5,410,415 equals 72x the median U.S. household income ($75,000).

Compensation History

Year-by-Year Detail

Year Organization Title Compensation Other Total
2024 BETH ISRAEL LAHEY HEALTH PHARMACY INC CEO (EX-OFF) (CEO, BILH) $4,313,387 $1,097,028 $5,410,415
2021 BETH ISRAEL LAHEY HEALTH PHARMACY INC CHIEF EXECUTIVE OFFICER (EX-OFFICIO) $3,378,281 $364,897 $3,743,178
2020 BIDMC PHARMACY INC DIRECTOR, PRESIDENT $2,488,251 $789,051 $3,277,302
2019 BIDMC PHARMACY INC DIRECTOR, PRESIDENT $1,756,953 $143,704 $1,900,657
2018 BIDMC PHARMACY INC DIRECTOR, PRESIDENT; CEO BIDMC $1,594,288 $204,209 $1,798,497

Peers at BETH ISRAEL LAHEY HEALTH PHARMACY INC

NameTitlePeak Comp.
Michael Rowan TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH $4.7M
Steven P Fischer DIRECTOR, TREASURER $1.7M
Cindy Rios TREAS (EX-OFF) (EXEC VP & CFO, BILH) $1.7M
Steven Fischer BILH CFO, TRUSTEE, TREASURER (EX-OFFICIO) $1.4M
Jamie Katz, ESQ CLERK (EX-OFF); GENERAL COUNSEL BILH $1.3M
Robert Fields, MD CHAIR&TTEE (CHIEF CLIN OFF, BILH) $1.3M
Jess Dejesus PRES/TTEE (EX-OFF); CHIEF PHARM OFF $910K
Efstathios Antoniades TRUSTEE $681K
Richard Fernandez TRUSTEE $670K
Jamie W Katz DIRECTOR, SECRETARY; SVP BIDMC $660K

Compare with another executive: Open comparison tool →